GABA-agonists as anti-epileptic agents.
D000818:Animals; D000927:Anticonvulsants; D001463:Barbiturates / Q000494:pharmacology; D001569:Benzodiazepines / Q000494:pharmacology; D004195:Disease Models, Animal; D004827:Epilepsy / Q000378:metabolism / Q000503:physiopathology; D005045:Etomidate / Q000494:pharmacology; D006885:Hydroxybutyrates / Q000494:pharmacology; D007539:Isonicotinic Acids / Q000494:pharmacology; D051379:Mice; D009118:Muscimol / Q000494:pharmacology; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D011963:Receptors, GABA-A; D012978:Sodium Oxybate; D005680:gamma-Aminobutyric Acid / Q000502:physiology*
D000927:Anticonvulsants; D001463:Barbiturates; D006885:Hydroxybutyrates; D007539:Isonicotinic Acids; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D012978:Sodium Oxybate; C015300:isoguvacine; D005045:Etomidate